[Sarcoidosis therapy and its problems today].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D002762:Cholecalciferol / Q000627:therapeutic use; D002908:Chronic Disease; D004893:Erythema Nodosum / Q000188:drug therapy; D005260:Female; D006801:Humans; D007978:Levamisole / Q000627:therapeutic use; D008171:Lung Diseases / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D010396:Penicillamine / Q000627:therapeutic use; D012507:Sarcoidosis / Q000188:drug therapy*; D013577:Syndrome; D014606:Uveitis, Anterior / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D002762:Cholecalciferol; D007978:Levamisole; D002738:Chloroquine; D000324:Adrenocorticotropic Hormone; D010396:Penicillamine; D001379:Azathioprine
Heutiger Stand der Sarkoidose-Therapie und ihrer Probleme.